Aurobindo Pharma Ltd. is committed to making a difference in the lives of millions of people by making medicines affordable and accessible for them across the globe.
Read More >>
Inaugurated our flagship Penicillin-G Facility at Kakinada,
Andhra Pradesh
With a portfolio of 830 US ANDAs fillings
We have a strong and sustainable pipeline of high value biosimilar programs with a primary focus on Oncology and Immunology therapeutic segments.
To access the comprehensive details of our annual performance, please click the link below to view our annual report.
Aurobindo Pharma Foundation, the philanthropic arm of Aurobindo Pharma Limited, strives to transform and uplift the lives of underserved communities.
Aurobindo Pharma commits itself to creating a more equitable and inclusive society by supporting processes that lead to a sustainable transformation.
The culture at Aurobindo is one of learning, collaboration, inclusivity with unlimited opportunities for our employees
Our 29 manufacturing facilities across the globe have a manufacturing capacities of50+ billion formulations units and 19,000+ MT APIs. and have advanced vertical integration to produce finished formulation products at an affordable price.
We are present across 150+ global markets including theUS, Europe and Growth Markets, and areranked amongst the top 10*** generic companies across eight countries in Europe.
Steadfast in our commitment to innovation & research, we invest significantly in our R&D.830 filings for ANDAs in the US, with 600+ approvals for the same.
Loading...
* Largest generic Pharma Company in the US (by Rx dispensed as per MAT March 2024)
** Global workforce including both permanent employees and contractual workers
*** Source: IQVIA data MAT Q3 2024
REGISTERED OFFICE
Plot no. 2, Maitrivihar, Ameerpet, Hyderabad-500038, Telangana, India.
CORPORATE OFFICE
Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City,
Raidurg Panmaktha, Rangareddy District,
Hyderabad - 500032, Telangana, India.
© Copyright 2025Aurobindo Pharma Limited. All rights reserved.
